Biofrontera (BFRIW) Revenue (2020 - 2025)

Biofrontera's Revenue history runs 6 years deep, the most recent figure standing at $17.1 million for Q4 2025.

• In Q4 2025, Revenue rose 36.16% year-over-year to $17.1 million; the TTM figure through Dec 2025 stood at $41.7 million (up 11.75% YoY), while the FY2025 annual figure was $41.7 million, up 11.75% from the prior year.
• Revenue was $17.1 million for Q4 2025 at Biofrontera, up from $7.0 million in the prior quarter.
• In the past five years, Revenue ranged from a high of $17.1 million in Q4 2025 to a low of $4.3 million in Q3 2022.
• Historically, Revenue has averaged $8.3 million across 5 years, with a median of $8.7 million in 2023.
• The sharpest annual moves came in 2022 and 2023: Revenue slipped 23.88% in 2022, then jumped 105.83% in 2023.
• A 5-year view of Revenue shows it stood at $9.2 million in 2021, then advanced by 10.65% to $10.1 million in 2022, then increased by 4.46% to $10.6 million in 2023, then climbed by 18.53% to $12.6 million in 2024, then jumped by 36.16% to $17.1 million in 2025.
• The last three Revenue figures came in at $17.1 million (Q4 2025), $7.0 million (Q3 2025), and $9.0 million (Q2 2025), per Business Quant data.